Literature DB >> 10438843

Thymocyte-thymic epithelial cell interaction leads to high-level replication of human immunodeficiency virus exclusively in mature CD4(+) CD8(-) CD3(+) thymocytes: a critical role for tumor necrosis factor and interleukin-7.

L Chêne1, M T Nugeyre, E Guillemard, N Moulian, F Barré-Sinoussi, N Israël.   

Abstract

This work aims at identifying the thymocyte subpopulation able to support human immunodeficiency virus (HIV) replication under the biological stimuli of the thymic microenvironment. In this report we demonstrate that interaction with thymic epithelial cells (TEC) induces a high-level replication of the T-tropic primary isolate HIV-1(B-LAIp) exclusively in the mature CD4(+) CD8(-) CD3(+) thymocytes. Tumor necrosis factor (TNF) and interleukin-7 (IL-7), secreted during this interaction, are critical cytokines for HIV long terminal repeat transactivation through NF-kappaB-dependent activation. TNF is the major inducer of NF-kappaB and particularly of the p50-p65 complex, whereas IL-7 acts as a cofactor by sustaining the expression of the p75 TNF receptor. The requirement for TNF is further confirmed by the observation that the inability of the intermediate CD4(+) CD8(-) CD3(-) thymocytes to replicate the virus is associated with a defect in TNF production during their interaction with TEC and correlates with the absence of nuclear NF-kappaB activity in these freshly isolated thymocytes. Addition of exogenous TNF to the intermediate thymocyte cultures induces NF-kappaB activity and is sufficient to promote HIV replication in the cocultures with TEC. The other major subpopulation expressing the CD4 receptor, namely, the double-positive (DP) CD4(+) CD8(+) CD3(+/-) thymocytes, despite the entry of the virus, do not produce a significant level of virus, presumably because they are unresponsive to TNF and IL-7. Together, these data suggest that in vivo, despite an efficient entry of the virus in all the CD4(+) subpopulations, a high viral load may be generated exclusively within the mature CD4(+) CD8(-) CD3(+) subset of thymocytes. However, under conditions of inflammatory response after infection, TNF might also be present in the intermediate thymocyte compartment, leading to efficient HIV replication in these cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10438843      PMCID: PMC104280     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  Immunopathologic changes in the thymus during the acute stage of experimentally induced feline immunodeficiency virus infection in juvenile cats.

Authors:  J C Woo; G A Dean; N C Pedersen; P F Moore
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease.

Authors:  B Autran; G Carcelain; T S Li; C Blanc; D Mathez; R Tubiana; C Katlama; P Debré; J Leibowitch
Journal:  Science       Date:  1997-07-04       Impact factor: 47.728

3.  Transient renewal of thymopoiesis in HIV-infected human thymic implants following antiviral therapy.

Authors:  E S Withers-Ward; R G Amado; P S Koka; B D Jamieson; A H Kaplan; I S Chen; J A Zack
Journal:  Nat Med       Date:  1997-10       Impact factor: 53.440

4.  Productive and persistent infection of human thymic epithelial cells in vitro with HIV-1.

Authors:  J Braun; H Valentin; M T Nugeyre; H Ohayon; P Gounon; F Barré-Sinoussi
Journal:  Virology       Date:  1996-11-15       Impact factor: 3.616

Review 5.  Rel/NF-kappa B transcription factors and the control of apoptosis.

Authors:  G E Sonenshein
Journal:  Semin Cancer Biol       Date:  1997-04       Impact factor: 15.707

Review 6.  I kappa B proteins: structure, function and regulation.

Authors:  S T Whiteside; A Israël
Journal:  Semin Cancer Biol       Date:  1997-04       Impact factor: 15.707

7.  Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice.

Authors:  K Akashi; M Kondo; U von Freeden-Jeffry; R Murray; I L Weissman
Journal:  Cell       Date:  1997-06-27       Impact factor: 41.582

8.  In vitro characterization of purified human thymic dendritic cells infected with human immunodeficiency virus type 1.

Authors:  S Beaulieu; A Kessous; D Landry; S Montplaisir; D Bergeron; E A Cohen
Journal:  Virology       Date:  1996-08-01       Impact factor: 3.616

9.  High-level replication of human immunodeficiency virus in thymocytes requires NF-kappaB activation through interaction with thymic epithelial cells.

Authors:  L Chêne; M T Nugeyre; F Barré-Sinoussi; N Israël
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

10.  Expression and function of the interleukin 7 receptor in murine lymphocytes.

Authors:  T Sudo; S Nishikawa; N Ohno; N Akiyama; M Tamakoshi; H Yoshida; S Nishikawa
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

View more
  15 in total

1.  Identification of T cell-signaling pathways that stimulate latent HIV in primary cells.

Authors:  David G Brooks; Philip A Arlen; Lianying Gao; Christina M R Kitchen; Jerome A Zack
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-20       Impact factor: 11.205

2.  IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART.

Authors:  Feng-Xiang Wang; Yan Xu; Julie Sullivan; Emily Souder; Elias G Argyris; Edward A Acheampong; Jaime Fisher; Maria Sierra; Michael M Thomson; Rafael Najera; Ian Frank; Joseph Kulkosky; Roger J Pomerantz; Giuseppe Nunnari
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

3.  Rapid and irreversible CD4+ T-cell depletion induced by the highly pathogenic simian/human immunodeficiency virus SHIV(DH12R) is systemic and synchronous.

Authors:  Tatsuhiko Igarashi; Charles R Brown; Russell A Byrum; Yoshiaki Nishimura; Yasuyuki Endo; Ronald J Plishka; Charles Buckler; Alicia Buckler-White; Georgina Miller; Vanessa M Hirsch; Malcolm A Martin
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

4.  Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection.

Authors:  John J Zaunders; Susanna Ip; Mee Ling Munier; Daniel E Kaufmann; Kazuo Suzuki; Choechoe Brereton; Sarah C Sasson; Nabila Seddiki; Kersten Koelsch; Alan Landay; Pat Grey; Robert Finlayson; John Kaldor; Eric S Rosenberg; Bruce D Walker; Barbara Fazekas de St Groth; David A Cooper; Anthony D Kelleher
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

5.  Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment.

Authors:  Yves Levy; Christine Lacabaratz; Laurence Weiss; Jean-Paul Viard; Cecile Goujard; Jean-Daniel Lelièvre; François Boué; Jean-Michel Molina; Christine Rouzioux; Véronique Avettand-Fénoêl; Thérèse Croughs; Stéphanie Beq; Rodolphe Thiébaut; Geneviève Chêne; Michel Morre; Jean-François Delfraissy
Journal:  J Clin Invest       Date:  2009-03-16       Impact factor: 14.808

Review 6.  Modulating T-cell homeostasis with IL-7: preclinical and clinical studies.

Authors:  C M Capitini; A A Chisti; C L Mackall
Journal:  J Intern Med       Date:  2009-08       Impact factor: 8.989

7.  Impact of cytokines on replication in the thymus of primary human immunodeficiency virus type 1 isolates from infants.

Authors:  Livia Pedroza-Martins; W John Boscardin; Deborah J Anisman-Posner; Dominique Schols; Yvonne J Bryson; Christel H Uittenbogaart
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

8.  Low and undetectable breast milk interleukin-7 concentrations are associated with reduced risk of postnatal HIV transmission.

Authors:  Jan Walter; Louise Kuhn; Mrinal K Ghosh; Chipepo Kankasa; Katherine Semrau; Moses Sinkala; Mwiya Mwiya; Donald M Thea; Grace M Aldrovandi
Journal:  J Acquir Immune Defic Syndr       Date:  2007-10-01       Impact factor: 3.731

9.  Increased interleukin-7 plasma levels are associated with recovery of CD4+ T cells in HIV-infected children.

Authors:  Rafael Correa; Salvador Resino; M Angeles Muñoz-Fernández
Journal:  J Clin Immunol       Date:  2003-09       Impact factor: 8.317

10.  Modalities of interleukin-7-induced human immunodeficiency virus permissiveness in quiescent T lymphocytes.

Authors:  Odile Ducrey-Rundquist; Mireille Guyader; Didier Trono
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.